Genomictree, Inc.(KR:228760)
â‚©8,700.00+300.00 (+3.57%)
KR:228760
Genomictree, Inc. financials statements
â‚©8,700.00
At close:+300.00 (+3.57%)
Want to see KR:228760 full AI Analyst Report?
Genomictree, Inc. (228760) Ratios
Genomictree, Inc. Ratios
KR:228760's free cash flow for Q1 2026 was ₩-2.94B. For the 2026 fiscal year, KR:228760's free cash flow was decreased by ₩-76.10M and operating cash flow was ₩-2.86B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 17.75 | 20.56 | 18.06 | 2.21 | 62.71 |
| Quick Ratio | 17.69 | 20.49 | 17.96 | 2.20 | 62.57 |
| Cash Ratio | 3.67 | 5.55 | 8.57 | 1.26 | 31.03 |
| Solvency Ratio | -1.46 | -1.42 | -0.97 | -0.09 | -0.17 |
| Operating Cash Flow Ratio | -1.63 | -2.87 | -2.06 | 0.08 | -3.56 |
| Short-Term Operating Cash Flow Coverage | -3.09 | -6.91 | -6.44 | 0.15 | 0.00 |
| Net Current Asset Value | â‚© 73.45B | â‚© 91.31B | â‚© 87.56B | â‚© 62.65B | â‚© 72.28B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.01 | 0.18 | 0.22 |
| Debt-to-Equity Ratio | 0.02 | 0.02 | 0.01 | 0.27 | 0.33 |
| Debt-to-Capital Ratio | 0.02 | 0.02 | 0.01 | 0.21 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 |
| Financial Leverage Ratio | 1.05 | 1.05 | 1.06 | 1.52 | 1.54 |
| Debt Service Coverage Ratio | -3.84 | -3.93 | -1.54 | 0.01 | -1.26 |
| Interest Coverage Ratio | -33.42 | -51.97 | -8.42 | 1.65 | -2.14 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.16 | 0.14 |
| Interest Debt Per Share | 112.70 | 100.24 | 173.66 | 1647.10 | 2083.82 |
| Net Debt to EBITDA | 1.36 | 2.73 | 6.93 | -12.70 | 4.83 |
| Profitability Margins | |||||
| Gross Profit Margin | 1.95% | -30.76% | -7.90% | 83.69% | 48.93% |
| EBIT Margin | -300.47% | -427.32% | -217.93% | 5.65% | -132.66% |
| EBITDA Margin | -273.34% | -376.61% | -183.47% | 10.13% | -112.77% |
| Operating Profit Margin | -300.47% | -648.24% | -506.24% | 29.81% | -191.75% |
| Pretax Profit Margin | -242.38% | -439.79% | -278.04% | -12.37% | -222.27% |
| Net Profit Margin | -238.98% | -433.58% | -256.17% | -20.88% | -222.28% |
| Continuous Operations Profit Margin | -242.68% | -439.84% | -263.51% | -20.88% | -222.28% |
| Net Income Per EBT | 98.60% | 98.59% | 92.14% | 168.88% | 100.01% |
| EBT Per EBIT | 80.67% | 67.84% | 54.92% | -41.49% | 115.92% |
| Return on Assets (ROA) | -7.44% | -7.84% | -6.59% | -3.83% | -6.45% |
| Return on Equity (ROE) | -7.81% | -8.27% | -7.02% | -5.83% | -9.93% |
| Return on Capital Employed (ROCE) | -9.71% | -12.16% | -13.56% | 8.13% | -5.63% |
| Return on Invested Capital (ROIC) | -9.52% | -11.97% | -12.68% | 6.43% | -5.62% |
| Return on Tangible Assets | -7.52% | -7.91% | -6.66% | -3.87% | -6.51% |
| Earnings Yield | -2.18% | -2.51% | -1.73% | -3.38% | -4.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.98 | 3.89 | 5.07 | 25.41 | 1.46 |
| Payables Turnover | 47.95 | 46.18 | 55.22 | 36.74 | 29.97 |
| Inventory Turnover | 13.90 | 9.23 | 7.43 | 7.67 | 9.21 |
| Fixed Asset Turnover | 0.19 | 0.13 | 0.20 | 1.67 | 0.24 |
| Asset Turnover | 0.03 | 0.02 | 0.03 | 0.18 | 0.03 |
| Working Capital Turnover Ratio | 0.04 | 0.03 | 0.04 | 0.30 | 0.04 |
| Cash Conversion Cycle | 110.41 | 125.42 | 114.56 | 52.04 | 276.79 |
| Days of Sales Outstanding | 91.76 | 93.79 | 72.03 | 14.36 | 249.35 |
| Days of Inventory Outstanding | 26.27 | 39.54 | 49.14 | 47.61 | 39.62 |
| Days of Payables Outstanding | 7.61 | 7.90 | 6.61 | 9.94 | 12.18 |
| Operating Cycle | 118.02 | 133.33 | 121.17 | 61.98 | 288.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -301.72 | -575.66 | -485.87 | 204.24 | -369.36 |
| Free Cash Flow Per Share | -415.27 | -683.43 | -498.75 | 117.31 | -941.88 |
| Dividend Paid and CapEx Coverage Ratio | -2.66 | -5.34 | -37.73 | 2.35 | -0.65 |
| Capital Expenditure Coverage Ratio | -2.66 | -5.34 | -37.73 | 2.35 | -0.65 |
| Operating Cash Flow Coverage Ratio | -3.06 | -6.56 | -5.93 | 0.15 | -0.20 |
| Operating Cash Flow to Sales Ratio | -1.93 | -5.77 | -3.18 | 0.14 | -1.48 |
| Free Cash Flow Yield | -2.41% | -3.97% | -2.21% | 1.33% | -7.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -45.96 | -39.77 | -57.80 | -29.57 | -24.05 |
| Price-to-Sales (P/S) Ratio | 109.82 | 172.44 | 148.07 | 6.18 | 53.46 |
| Price-to-Book (P/B) Ratio | 3.59 | 3.29 | 4.06 | 1.72 | 2.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -41.42 | -25.17 | -45.31 | 74.93 | -14.12 |
| Price-to-Operating Cash Flow Ratio | -57.01 | -29.88 | -46.51 | 43.04 | -36.01 |
| Price-to-Earnings Growth (PEG) Ratio | 3.41 | -3.75 | -1.83 | 0.64 | 4.22 |
| Enterprise Value Multiple | -38.82 | -43.06 | -73.78 | 48.30 | -42.57 |
| Enterprise Value | 398.99B | 383.08B | 462.67B | 146.05B | 246.75B |
| EV to EBITDA | -38.82 | -43.06 | -73.78 | 48.30 | -42.57 |
| EV to Sales | 106.11 | 162.16 | 135.36 | 4.89 | 48.01 |
| EV to Free Cash Flow | -40.02 | -23.67 | -41.42 | 59.34 | -12.68 |
| EV to Operating Cash Flow | -55.08 | -28.10 | -42.52 | 34.08 | -32.34 |
| Tangible Book Value Per Share | 4751.28 | 5196.54 | 5522.70 | 5051.71 | 5490.61 |
| Shareholders’ Equity Per Share | 4792.97 | 5230.96 | 5570.09 | 5101.83 | 5571.42 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.05 | -0.69 | -0.00 |
| Revenue Per Share | 156.62 | 99.75 | 152.63 | 1423.29 | 248.78 |
| Net Income Per Share | -374.28 | -432.48 | -391.00 | -297.25 | -553.00 |
| Tax Burden | 0.99 | 0.99 | 0.92 | 1.69 | 1.00 |
| Interest Burden | 0.81 | 1.03 | 1.28 | -2.19 | 1.68 |
| Research & Development to Revenue | 0.97 | 2.09 | 1.28 | 0.18 | 0.55 |
| SG&A to Revenue | 1.94 | 1.06 | 0.85 | 0.30 | 0.65 |
| Stock-Based Compensation to Revenue | 0.00 | 0.82 | 0.48 | 0.01 | 0.14 |
| Income Quality | 0.81 | 1.31 | 1.21 | -0.69 | 0.67 |
Currency in KRW

